# Study of Exposure to Substances Prohibited by the World Anti-Doping Agency in Healthy Volunteers.

> **NCT04757532** · PHASE1 · COMPLETED · sponsor: **Parc de Salut Mar** · enrollment: 9 (actual)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** Bupropion
- **DRUG:** Anastrozole
- **DRUG:** Testosterone cyclopentylpropionate
- **DRUG:** Danazol
- **DRUG:** Chlorthalidone

## Key facts

- **NCT ID:** NCT04757532
- **Lead sponsor:** Parc de Salut Mar
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-12-03
- **Primary completion:** 2021-03-10
- **Final completion:** 2021-03-10
- **Target enrollment:** 9 (ACTUAL)
- **Last updated:** 2021-04-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04757532

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04757532, "Study of Exposure to Substances Prohibited by the World Anti-Doping Agency in Healthy Volunteers.". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04757532. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*